Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
Conditions
Brief summary
This study assesses patient awareness and understanding of cancer clinical trials.
Detailed description
PRIMARY OBJECTIVE: I. To develop a multi-level data-driven intervention to improve cancer patient engagement with cancer clinical trials. OUTLINE: This is an observational study. Patients review educational materials and complete surveys on study.
Interventions
Non-interventional study
Sponsors
Study design
Eligibility
Inclusion criteria
* Eligible patient participants will be: * Black/African American, Asian/Asian American, White or Hispanic adults of any gender 21 years of age or older. Race/ethnicity will be self-reported * Have been diagnosed any cancer type
Exclusion criteria
* Participants (patients) will be excluded if they: * Are unable to give informed consent * Are unable to speak English or Spanish
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in Baseline Survey Score | Through study completion, up to 1 year | The survey is a validated instrument (CHEKS\*) evaluated patients' knowledge and beliefs about cancer clinical trials (CCTs) before and after exposure to educational stimuli (written and video) detailing the purpose and characteristics of CCTs. The survey scores knowledge and beliefs about CCTs on a 100-point scale.The survey is collected before and after education materials are provided. The change in survey score will be analyzed. A paired t-test will be used to examine changes in CCT knowledge and Chi-Square tests of association to determine whether CCT knowledge and beliefs are associated with sociodemographic variables. \*Chung A, Donley T, Hays RD, et al. Development and evaluation of the Clinical Trial HEalth Knowledge and Beliefs Scale (CHEKS). Int J Environ Res Public Health. 2022;19(14):8660. doi:10.3390/ijerph19148660 |
Countries
United States
Contacts
University of Southern California